SunRock Biopharma

SunRock is a biotech company devoted to the development of antibodies against highly invasive tumors with an urgent clinical need in oncology.

Oficinas de empresa

SunRock es una compañía biotecnológica dedicada al desarrollo de anticuerpos para el tratamiento de tumores altamente invasivos con necesidades urgentes de terapias oncológicas.

Servicios: Aseos

Chemokine receptor 9, CCR9, is overexpressed in solid and hematologic tumors. CCR9 promotes metastatis and the development of resistance to conventional treatments in these tumors.
SunRock has developed a novel anti-CCR9 antibody with improved target affinity and immune-mediated anti-tumor activity. Its efficacy and safety have been demonstrated in preclinical in vitro and in vivo models of relevance to the pharmaceutical industry.